Open AccessEfficacy of Prokinetic Itopride in Type 2 Diabetes Mellitus
Author(s) -
А. Е. Шкляев,
Д. Д. Казарин,
Ю. В. Горбунов
Publication year - 2020
Publication title -
èksperimentalʹnaâ i kliničeskaâ gastroènterologiâ
Language(s) - English
Resource type - Journals
ISSN - 1682-8658
DOI - 10.31146/1682-8658-ecg-181-9-35-39
Subject(s) - medicine , esophagogastroduodenoscopy , diabetes mellitus , type 2 diabetes mellitus , gastroenterology , gastroparesis , stomach , mosapride , chronic gastritis , gastritis , type 2 diabetes , helicobacter pylori , incidence (geometry) , blood sugar , gastrointestinal function , gastric emptying , endoscopy , endocrinology , physics , optics
The constant increase in the incidence of diabetes in the world and the high frequency of lesions of the upper gastrointestinal tract with impaired motor function in this category of patients, on the one hand, worsen the clinical picture, and on the other, reduce the effectiveness of sugar-lowering therapy. Currently, specialists have at their disposal a number of prokinetics that contribute to the restoration of the motor-evacuation function of the stomach, but many of them have many undesirable effects. The aim of our study was to evaluate the effectiveness of itopride hydrochloride in the treatment of patients with chronic gastritis associated with Helicobacter pylori and type 2 diabetes. During the study, both general clinical and more specific research methods were used, in particular, esophagogastroduodenoscopy. According to the results of the study, the use of prokinetics in the treatment of patients with type 2 diabetes mellitus reduces the manifestations of impaired motor-evacuation function of the upper gastrointestinal tract. The results obtained indicate to verify the manifestations of chronic gastritis in patients with type 2 diabetes mellitus and the identification of motor dysfunction and the need for prokinetic therapy.